Trials / Completed
CompletedNCT03101150
Effect of Vitamin D3 Supplementation in Pregnancy on Risk of Pre-eclampsia
Effect of Antenatal Vitamin D3 Supplementation on Risk of Pre-eclampsia
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 179 (actual)
- Sponsor
- King Fahad Medical City · Other Government
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Vitamin D deficient pregnant ladies were selected and randomized into 2 groups for routine daily dose of multivitamin (400IU vitamin D3) versus maximum safest treatment daily dose (4000IU vitamin D3). Participants were assessed and compared for number of pre-eclampsia cases.
Detailed description
Vitamin D3 has key role in decidualization and implantation of placenta.Vitamin D deficiency is thought to have positive association with pre-eclampsia.Vitamin D deficiency is highly prevalent in some parts of the world and it is not universally screened antenatally. Pre-eclampsia is a known multifactorial pregnancy disorder with significant maternal and perinatal morbidity and mortality. Vitamin D3 has a down-regulating effect on inflammatory pathways and reducing endothelial cell damage. Investigators want to assess in vitamin D deficient group whether treatment reduces the risk of pre-eclampsia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 400 IU Vitamin D3 | Antenatal multivitamin |
| DRUG | 4000 IU Vitamin D3 | 4000 IU Vitamin D3 (cholecalciferol) daily = 40 drops daily |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-10-31
- Completion
- 2015-12-31
- First posted
- 2017-04-04
- Last updated
- 2018-11-02
- Results posted
- 2018-11-02
Source: ClinicalTrials.gov record NCT03101150. Inclusion in this directory is not an endorsement.